Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2005 1
2006 1
2007 3
2008 2
2009 1
2010 2
2011 3
2012 5
2013 4
2014 4
2015 4
2016 6
2017 3
2018 1
2019 1
2020 2
2021 1
2022 3
2023 8

Text availability

Article attribute

Article type

Publication date

Search Results

50 results

Results by year

Filters applied: . Clear all
Page 1
Narrative Review of Drug-Associated Nail Toxicities in Oncologic Patients.
Emvalomati A, Oflidou V, Papageorgiou C, Kemanetzi C, Giannouli M, Kalloniati E, Efthymiadis K, Koukoutzeli C, Timotheadou E, Trigoni A, Patsatsi A, Lazaridou E, Apalla Z, Trakatelli M. Emvalomati A, et al. Among authors: timotheadou e. Dermatol Pract Concept. 2023 Jan 1;13(1):e2023064. doi: 10.5826/dpc.1301a64. Dermatol Pract Concept. 2023. PMID: 36892360 Free PMC article. Review.
Management of Cancer-associated Thrombosis (CAT): Symptomatic or Incidental.
Papakotoulas P, Tsoukalas N, Christopoulou A, Ardavanis A, Koumakis G, Papandreou C, Papatsimpas G, Papakostas P, Samelis G, Andreadis C, Aravantinos G, Ziras N, Kalofonos C, Samantas E, Souggleri M, Makrantonakis P, Pentheroudakis G, Athanasiadis A, Stergiou H, Tripodaki S, Bokas A, Grivas A, Timotheadou E, Bournakis E, Varthalitis I, Boukovinas I. Papakotoulas P, et al. Among authors: timotheadou e. Anticancer Res. 2020 Jan;40(1):305-313. doi: 10.21873/anticanres.13954. Anticancer Res. 2020. PMID: 31892581
New agents targeting angiogenesis in glioblastoma.
Timotheadou E. Timotheadou E. Chemother Res Pract. 2011;2011:878912. doi: 10.1155/2011/878912. Epub 2011 Nov 2. Chemother Res Pract. 2011. PMID: 22295207 Free PMC article.
Prophylaxis of cancer-associated venous thromboembolism with low-molecular-weight heparin-tinzaparin: Real world evidence.
Christopoulou A, Ardavanis A, Papandreou C, Koumakis G, Papatsimpas G, Papakotoulas P, Tsoukalas N, Andreadis C, Samelis G, Papakostas P, Aravantinos G, Ziras N, Souggleri M, Kalofonos C, Samantas E, Makrantonakis P, Pentheroudakis G, Athanasiadis A, Stergiou H, Bokas A, Grivas A, Tripodaki ES, Varthalitis I, Timotheadou E, Boukovinas I. Christopoulou A, et al. Among authors: timotheadou e. Oncol Lett. 2022 Apr;23(4):115. doi: 10.3892/ol.2022.13235. Epub 2022 Feb 9. Oncol Lett. 2022. PMID: 35251346 Free PMC article.
A retrospective multicentric cohort study of checkpoint inhibitors-induced pruritus with focus on management.
Papageorgiou C, Lazaridou E, Lallas K, Papaioannou K, Nikolaou V, Mateeva V, Efthymiadis K, Koukoutzeli C, Loga K, Sogka E, Karamitrousis E, Lazaridis G, Dionysopoulos D, Lallas A, Kemanetzi C, Fotiadou C, Timotheadou E, Apalla Z. Papageorgiou C, et al. Among authors: timotheadou e. Photodermatol Photoimmunol Photomed. 2023 Sep;39(5):506-511. doi: 10.1111/phpp.12892. Epub 2023 Jun 12. Photodermatol Photoimmunol Photomed. 2023. PMID: 37306213
Real-World Data on Thromboprophylaxis in Active Cancer Patients: Where Are We? Are We Getting There?
Tsoukalas N, Papakotoulas P, Christopoulou A, Ardavanis A, Koumakis G, Papandreou C, Papatsimpas G, Papakostas P, Samelis G, Andreadis C, Aravantinos G, Ziras N, Kalofonos C, Samantas E, Souggleri M, Makrantonakis P, Pentheroudakis G, Athanasiadis A, Stergiou H, Tripodaki ES, Bokas A, Grivas A, Timotheadou E, Bournakis E, Varthalitis I, Boukovinas I. Tsoukalas N, et al. Among authors: timotheadou e. Cancers (Basel). 2020 Jul 15;12(7):1907. doi: 10.3390/cancers12071907. Cancers (Basel). 2020. PMID: 32679747 Free PMC article.
Opposite Prognostic Impact of Single PTEN-loss and PIK3CA Mutations in Early High-risk Breast Cancer.
Lazaridis G, Kotoula V, Vrettou E, Kostopoulos I, Manousou K, Papadopoulou K, Giannoulatou E, Bobos M, Sotiropoulou M, Pentheroudakis G, Efstratiou I, Papoudou-Bai A, Psyrri A, Christodoulou C, Gogas H, Koutras A, Timotheadou E, Pectasides D, Zagouri F, Fountzilas G. Lazaridis G, et al. Among authors: timotheadou e. Cancer Genomics Proteomics. 2019 May-Jun;16(3):195-206. doi: 10.21873/cgp.20125. Cancer Genomics Proteomics. 2019. PMID: 31018950 Free PMC article.
50 results